Search results
Bristol-Myers Squibb (NYSE:BMY) Releases Earnings Results, Beats Expectations By $0.13 EPS
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($4.40) EPS for the quarter, beating the consensus ...
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
NBC Connecticut· 7 days agoBristol Myers Squibb reported first-quarter revenue that topped expectations as its blockbuster...
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
CNBC· 7 days agoBristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its...
Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site
FierceBiotech· 6 days agoOne of Chris Boerner’s first tours as the new CEO of Bristol Myers Squibb was of a 256,000...
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
The Wall Street Journal· 7 days agoBristol-Myers Squibb’s market capitalization has dropped so much over the past year that it is now...
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
GuruFocus.com via Yahoo Finance· 6 days agoComprehensive SWOT analysis based on the latest SEC 10-Q filing. Insight into Bristol-Myers Squibb's...
Analyzing Bristol-Myers Squibb Co.
Knox Daily· 3 days agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...
Bristol-Myers Squibb Co (BMY) Q1 2024 Earnings Report: A Detailed Overview
GuruFocus.com via Yahoo Finance· 7 days agoRevenue: Reported at $11.9 billion, up 5% year-over-year, exceeding the estimate of $11.457 billion....
Bristol Myers Squibb shares fall amid sluggish sales of some newer drugs
Market Watch· 7 days agoBristol Myers Squibb Co. shares fell 2% premarket on Thursday after the company reported...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 6 days agoFor Immediate Release Chicago, IL – April 26, 2024 – Zacks.com announces the list of stocks featured...
